Daniel K. Spiegelman - 26 Jun 2026 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Reporting relationship: Director
Issuer ticker: VTVT
Reported as of: 26 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jun 2026, 16:10:19 UTC
Prior SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Keiley, as Attorney-in-fact

Key filing fact

Daniel K. Spiegelman filed Form 4 for vTv Therapeutics Inc. (VTVT) on 29 Jun 2026.

Key facts

This page summarizes Daniel K. Spiegelman's Form 4 filing for vTv Therapeutics Inc. (VTVT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Jun 2026, 16:10.

Change

Previous filing in this sequence was filed on 10 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001238403 Primary reporting owner

SPIEGELMAN DANIEL K

Relationship: Director
Address: C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 110, HIGH POINT
Signature: /s/ Elizabeth Keiley, as Attorney-in-fact
Signature date: 29 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTVT transaction Derivative

Director stock option (right to buy)

Award

Transaction value
Shares: +6,000
Change %: +60%
Price: $35.08^*
Shares after: 16,000
Date: 26 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 6,000
Exercise price: $35.08
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests on the earlier of June 26, 2027, and the date of the 2027 annual general meeting of shareholders, subject to the director's continued service on the board of directors through such vesting.